Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This program meets the criteria of the Massachusetts Board of Registration in Medicine for opioid education.


• Describe the mission and philosophy of Faster Paths
• List the elements that patients define as contributing to their recovery
• Discuss the barriers to recovery described by these patients


Target Audience

MDs, APRNs, psych residents, medical studentgs, psych social work therapists, psychologists, providers from GIM and Family Medicine 

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement:

Eric Achtyes, Speaker, has no relevant financial relationships to disclose.

Marion Burke, Co-Course Director, has no relevant financial relationships to disclose.

Sakina Flint, Program Manager, has no relevant financial relationships to disclose.

Faculty disclosure of off-label use:

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.